Morinaga&Co Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Morinaga&Co heeft een totaal eigen vermogen van ¥137.2B en een totale schuld van ¥19.0B, wat de schuld-eigenvermogensverhouding op 13.8% brengt. De totale activa en totale passiva bedragen respectievelijk ¥220.1B en ¥82.9B. De EBIT Morinaga&Co is ¥19.9B waardoor de rentedekking -70.4 is. Het heeft contanten en kortetermijnbeleggingen van ¥44.1B.

Belangrijke informatie

13.8%

Verhouding schuld/eigen vermogen

JP¥19.00b

Schuld

Rente dekkingsratio	-70.4x
Contant	JP¥44.15b
Aandelen	JP¥137.22b
Totaal verplichtingen	JP¥82.91b
Totaal activa	JP¥220.12b

Recente financiële gezondheidsupdates

Does Morinaga&Co (TSE:2201) Have A Healthy Balance Sheet?

Oct 25

Is Morinaga&Co (TSE:2201) A Risky Investment?

Mar 05

Recent updates

Morinaga&Co (TSE:2201) Is Increasing Its Dividend To ¥60.00

Nov 14

Does Morinaga&Co (TSE:2201) Have A Healthy Balance Sheet?

Oct 25

An Intrinsic Calculation For Morinaga&Co., Ltd. (TSE:2201) Suggests It's 37% Undervalued

Oct 09

Morinaga&Co., Ltd.'s (TSE:2201) Earnings Haven't Escaped The Attention Of Investors

Jul 13

Returns On Capital At Morinaga&Co (TSE:2201) Have Hit The Brakes

Apr 19

Risks To Shareholder Returns Are Elevated At These Prices For Morinaga&Co., Ltd. (TSE:2201)

Mar 20

Is Morinaga&Co (TSE:2201) A Risky Investment?

Mar 05

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ¥114.2B ) 2201 } overtreffen de korte termijn passiva ( ¥56.4B ).

Langlopende schulden: De kortetermijnactiva 2201 ( ¥114.2B ) overtreffen de langetermijnschulden ( ¥26.5B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 2201 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 2201 is de afgelopen 5 jaar gestegen van 10.5% naar 13.8%.

Schuldendekking: De schuld van 2201 wordt goed gedekt door de operationele kasstroom ( 121.6% ).

Rentedekking: 2201 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Morinaga&Co Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Does Morinaga&Co (TSE:2201) Have A Healthy Balance Sheet?

Is Morinaga&Co (TSE:2201) A Risky Investment?

Recent updates

Morinaga&Co., Ltd. (TSE:2201) announces an Equity Buyback for 4,200,000 shares, representing 4.68% for ¥10,000 million.

Second quarter 2025 earnings: EPS misses analyst expectations

Morinaga&Co (TSE:2201) Is Increasing Its Dividend To ¥60.00

Dividend of JP¥60.00 announced

Does Morinaga&Co (TSE:2201) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Morinaga&Co., Ltd. (TSE:2201) Suggests It's 37% Undervalued

Morinaga&Co., Ltd.'s (TSE:2201) Earnings Haven't Escaped The Attention Of Investors

Full year 2024 earnings: EPS exceeds analyst expectations

Morinaga&Co., Ltd., Annual General Meeting, Jun 27, 2024

Morinaga&Co., Ltd. Resolves Dividend for the Year Ended March 31, 2024, Payable on June 28, 2024

Returns On Capital At Morinaga&Co (TSE:2201) Have Hit The Brakes

Morinaga&Co., Ltd. to Report Q2, 2025 Results on Nov 12, 2024

Upcoming dividend of JP¥55.00 per share

Risks To Shareholder Returns Are Elevated At These Prices For Morinaga&Co., Ltd. (TSE:2201)

Is Morinaga&Co (TSE:2201) A Risky Investment?

Morinaga&Co., Ltd. to Report Fiscal Year 2024 Results on May 10, 2024

Third quarter 2024 earnings: Revenues exceed analyst expectations

Morinaga&Co., Ltd. Revises Dividend Guidance for the Year Ending March 31, 2024

Now 21% undervalued

New minor risk - Shareholder dilution

Price target increased by 8.3% to JP¥6,388

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Morinaga&Co., Ltd. Provides Dividend Guidance for the Year Ending Mar. 31, 2024

First quarter 2024 earnings released: EPS: JP¥93.35 (vs JP¥69.25 in 1Q 2023)

Price target increased by 19% to JP¥5,233

Full year 2023 earnings: EPS exceeds analyst expectations

Morinaga & Co.,Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 2023 and Year Ending March 2024

Morinaga&Co., Ltd. Approves Dividend Guidance for the Year Ending March 31, 2023

Price target increased by 8.3% to JP¥4,667

Upcoming dividend of JP¥90.00 per share at 2.4% yield

Third quarter 2023 earnings released: EPS: JP¥47.61 (vs JP¥59.08 in 3Q 2022)

Morinaga&Co., Ltd. (TSE:2201) announces an Equity Buyback for 800,000 shares, representing 1.67% for ¥4,000 million.

Morinaga&Co., Ltd. Revises Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2023

Consensus forecasts updated

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥65.53 (vs JP¥93.73 in 2Q 2022)

Morinaga&Co., Ltd. Revises Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2023

First quarter 2023 earnings released: EPS: JP¥69.25 (vs JP¥96.03 in 1Q 2022)

Morinaga&Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2023

Full year 2022 earnings: EPS exceeds analyst expectations

Morinaga & Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 2022 and Full Year Ending March 2023

Morinaga & Co., Ltd., Annual General Meeting, Jun 29, 2022

Less than half of directors are independent

Upcoming dividend of JP¥80.00 per share

Consensus forecasts updated

Morinaga & Co., Ltd. (TSE:2201) announces an Equity Buyback for 3,000,000 shares, representing 5.96% for ¥10,000 million.

Morinaga & Co., Ltd. Revises Consolidated Earnings Guidance for Fiscal Year Ending March 31, 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Morinaga & Co., Ltd. Provides Consolidated Earnings Guidance for Fiscal Year Ending March 31, 2022

Morinaga & Co., Ltd. Provides Dividend Guidance for Year Ending March 31, 2022

Second quarter 2022 earnings released: EPS JP¥93.72 (vs JP¥86.09 in 2Q 2021)

Price target increased to JP¥4,377

First quarter 2022 earnings released: EPS JP¥96.03 (vs JP¥79.22 in 1Q 2021)

Price target decreased to JP¥3,970

Consensus revenue estimates fall to JP¥170.7b

Full year 2021 earnings released: EPS JP¥267 (vs JP¥215 in FY 2020)

Morinaga & Co., Ltd. Announces Year End Dividend for the Year Ended March 31, 2021, Payable on June 30, 2021

Upcoming dividend of JP¥72.00 per share

New 90-day low: JP¥3,815

Morinaga & Co., Ltd. to Report Q2, 2022 Results on Nov 10, 2021

Third quarter 2021 earnings released: EPS JP¥77.18 (vs JP¥81.91 in 3Q 2020)

Revenue beats expectations, earnings disappoint

New 90-day high: JP¥4,370

Price target lowered to JP¥4,765

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven